La metformine est associée à une moindre mortalité chez les patients diabétiques hospitalisés pour la COVID-19

Metformin exerts anti-inflammatory and immunosuppressive effects. We addressed the impact of prior metformin use on the prognosis of patients with type 2 diabetes hospitalised for COVID-19. We used data from the nationwide observational CORONADO cohort that included patients with diabetes hospitalis...

Descripción completa

Detalles Bibliográficos
Autores principales: Lalau, Jean-Daniel, Al-Salameh, Abdallah, Wiernsperger, Nicolas, Goronflot, Thomas, Pichelin, Matthieu, Wargny, Matthieu, Desailloud, Rachel, Hadjad, Samy, Gourdy, Pierre, Cariou, Bertrand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2021
Materias:
Mini Dossier
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904517/
http://dx.doi.org/10.1016/j.mmm.2021.02.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904517/
http://dx.doi.org/10.1016/j.mmm.2021.02.013

Ejemplares similares